{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:52:16Z","timestamp":1767829936184,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10067-020-04945-4","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T20:02:15Z","timestamp":1579377735000},"page":"1851-1858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bristol rheumatoid arthritis fatigue scale is valid in patients with psoriatic arthritis and is associated with overall severe disease and higher comorbidities"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7383-7990","authenticated-orcid":false,"given":"Muhammad","family":"Haroon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Szentpetery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsin","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,18]]},"reference":[{"key":"4945_CR1","unstructured":"Hewlett S, Nicklin J, Treharne GJ (2008) Fatigue in musculoskeletal conditions.Topical reviews series 6: no 1. Arthritis Research UK. http:\/\/www.arthritisresearchuk.org\/files\/6641_25022010173830.pdf"},{"key":"4945_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/art.21450","volume":"53","author":"S Hewlett","year":"2005","unstructured":"Hewlett S, Cockshott Z, Byron M, Kitchen K, Tipler S, Pope D, Hehir M (2005) Patients\u2019 perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum 53:697\u2013702","journal-title":"Arthritis Rheum"},{"key":"4945_CR3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ijnurstu.2007.06.007","volume":"45","author":"H Repping-Wuts","year":"2008","unstructured":"Repping-Wuts H, Uitterhoeve R, van Riel P, van Achterberg T (2008) Fatigue as experienced by patients with rheumatoid arthritis (RA): a qualitative study. Int J Nurs Stud 45:995\u20131002","journal-title":"Int J Nurs Stud"},{"key":"4945_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2474-9-63","volume":"9","author":"JD Power","year":"2008","unstructured":"Power JD, Badley EM, French MR, Wall AJ, Hawker GA (2008) Fatigue in osteoarthritis: a qualitative study. BMC Musculoskelet Disord 9:63","journal-title":"BMC Musculoskelet Disord"},{"key":"4945_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/NNR.0b013e318283fcb3","volume":"62","author":"AL Franklin","year":"2013","unstructured":"Franklin AL, Harrell TH (2013) Impact of fatigue on psychological outcomes in adults living with rheumatoid arthritis. Impact of fatigue on psychological outcomes in adults living with rheumatoid arthritis. Nurs Res 62:203\u2013209","journal-title":"Nurs Res"},{"key":"4945_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/art.20539","volume":"51","author":"I Rupp","year":"2004","unstructured":"Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos GA (2004) Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum 51:578\u2013585","journal-title":"Arthritis Rheum"},{"key":"4945_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/1529-0131(200104)45:2<111::AID-ANR162>3.0.CO;2-E","volume":"45","author":"TP Suurmeijer","year":"2001","unstructured":"Suurmeijer TP, Waltz M, Moum T, Guillemin F, van Sonderen FL, Brian\u00e7on S, Sanderman R et al (2001) Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study. Arthritis Rheum 45:111\u2013121","journal-title":"Arthritis Rheum"},{"key":"4945_CR8","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","volume":"73","author":"L Gossec","year":"2014","unstructured":"Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, Maccarone M et al (2014) A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 73:1012\u20131019","journal-title":"Ann Rheum Dis"},{"key":"4945_CR9","first-page":"1167","volume":"34","author":"DD Gladman","year":"2007","unstructured":"Gladman DD, Mease PJ, Strand V, Healy P, Helliwell PS, Fitzgerald O, Gottlieb AB, Krueger GG, Nash P, Ritchlin CT, Taylor W, Adebajo A, Braun J, Cauli A, Carneiro S, Choy E, Dijkmans B, Espinoza L, van der Heijde D, Husni E, Lubrano E, McGonagle D, Qureshi A, Soriano ER, Zochling J (2007) Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 34:1167\u20131170","journal-title":"J Rheumatol"},{"key":"4945_CR10","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3899\/jrheum.160904","volume":"44","author":"AM Orbai","year":"2017","unstructured":"Orbai AM, de Wit M, Mease PJ, Callis Duffin K, Elmamoun M, Tillett W, Campbell W, FitzGerald O, Gladman DD, Goel N, Gossec L, Hoejgaard P, Leung YY, Lindsay C, Strand V, van der Heijde D, Shea B, Christensen R, Coates L, Eder L, McHugh N, Kalyoncu U, Steinkoenig I, Ogdie A (2017) Updating the psoriatic arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016. J Rheumatol 44:1522\u20131528","journal-title":"J Rheumatol"},{"key":"4945_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00006199-199303000-00006","volume":"42","author":"BL Belza","year":"1993","unstructured":"Belza BL, Henke CJ, Yelin EH, Epstein WV, Gilliss CL (1993) Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 42:93\u201399","journal-title":"Nurs Res"},{"key":"4945_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473\u2013483","journal-title":"Med Care"},{"key":"4945_CR13","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","volume":"85","author":"TR Mendoza","year":"1999","unstructured":"Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL (1999) The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85:1186\u20131196","journal-title":"Cancer"},{"key":"4945_CR14","first-page":"1407","volume":"23","author":"F Wolfe","year":"1996","unstructured":"Wolfe F, Hawley DJ, Wilson K (1996) The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 23:1407\u20131417","journal-title":"J Rheumatol"},{"key":"4945_CR15","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121\u20131123","journal-title":"Arch Neurol"},{"key":"4945_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/ard.2006.065763","volume":"66","author":"V Chandran","year":"2007","unstructured":"Chandran V, Bhella S, Schentag C, Gladman DD (2007) Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis 66:936\u2013939","journal-title":"Ann Rheum Dis"},{"key":"4945_CR17","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1002\/art.21306","volume":"52","author":"PJ Mease","year":"2005","unstructured":"Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld SD, Choy EH, Sharp JT, Ory PA, Perdok RJ, Weinberg MA, Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group (2005) Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 52:3279\u20133289","journal-title":"Arthritis Rheum"},{"key":"4945_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","volume":"367","author":"S Tyring","year":"2006","unstructured":"Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367:29\u201335","journal-title":"Lancet"},{"key":"4945_CR19","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1093\/rheumatology\/ket218","volume":"52","author":"EK Dures","year":"2013","unstructured":"Dures EK, Hewlett SE, Cramp FA, Greenwood R, Nicklin JK, Urban M, Kirwan JR (2013) Reliability and sensitivity to change of the Bristol rheumatoid arthritis fatigue scales. Rheumatology (Oxford) 52:1832\u20131839","journal-title":"Rheumatology (Oxford)"},{"key":"4945_CR20","first-page":"127","volume":"62","author":"DD Gladman","year":"1987","unstructured":"Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK (1987) Psoriatic arthritis (PSA) \u2014 an analysis of 220 patients. Q J Med 62:127\u2013141","journal-title":"Q J Med"},{"key":"4945_CR21","first-page":"1126","volume":"31","author":"DD Gladman","year":"2004","unstructured":"Gladman DD, Cook RJ, Schentag C, Feletar M, Inman RD, Hitchon C et al (2004) The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada. J Rheumatol 31:1126\u20131131","journal-title":"J Rheumatol"},{"issue":"1","key":"4945_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","volume":"69","author":"LC Coates","year":"2010","unstructured":"Coates LC, Fransen J, Helliwell PS (2010) Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 69(1):48\u201353","journal-title":"Ann Rheum Dis"},{"key":"4945_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"4945_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the functional assessment of Cancer therapy (FACT) measurement system. J Pain Symptom Manag 13:63\u201374","journal-title":"J Pain Symptom Manag"},{"key":"4945_CR25","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1136\/ard.2008.098202","volume":"68","author":"JA Husted","year":"2009","unstructured":"Husted JA, Tom BD, Schentag CT, Farewell VT, Gladman DD (2009) Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis 68:1553\u20131558","journal-title":"Ann Rheum Dis"},{"key":"4945_CR26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/bjd.15258","volume":"176","author":"AM Tobin","year":"2017","unstructured":"Tobin AM, Sadlier M, Collins P, Rogers S, FitzGerald O, Kirby B (2017) Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study. Br J Dermatol 176:827\u2013828","journal-title":"Br J Dermatol"},{"key":"4945_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jbspin.2015.07.017","volume":"83","author":"T Gudu","year":"2016","unstructured":"Gudu T, Etcheto A, de Wit M, Heiberg T, Maccarone M, Balanescu A, Balint PV, Niedermayer DS, Ca\u00f1ete JD, Helliwell P, Kalyoncu U, Kiltz U, Otsa K, Veale DJ, de Vlam K, Scrivo R, Stamm T, Kvien TK, Gossec L (2016) Fatigue in psoriatic arthritis \u2013 a cross-sectional study of 246 patients from 13 countries. Joint Bone Spine 83:439\u2013443","journal-title":"Joint Bone Spine"},{"issue":"Suppl 9","key":"4945_CR28","first-page":"S424","volume":"46","author":"C Schentag","year":"2002","unstructured":"Schentag C, Gladman DD (2002) Changes in fatigue in psoriatic arthritis: disease activity or fibromyalgia [abstract]. Arthritis Rheum 46(Suppl 9):S424","journal-title":"Arthritis Rheum"},{"key":"4945_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/bjd.15375","volume":"177","author":"IM Skoie","year":"2017","unstructured":"Skoie IM, Dalen I, Ternowitz T, Jonsson G, Kvivik I, Norheim K, Omdal R (2017) Fatigue in psoriasis \u2013 a controlled study. Br J Dermatol 177:505\u2013512","journal-title":"Br J Dermatol"},{"key":"4945_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/art.39973","volume":"69","author":"L Eder","year":"2017","unstructured":"Eder L, Polachek A, Rosen CF, Chandran V, Cook R, Gladman DD (2017) The development of PsA in patients with psoriasis is preceded by a period of non-specific musculoskeletal symptoms: a prospective cohort study. Arthritis Rheum 69:622\u2013629","journal-title":"Arthritis Rheum"},{"key":"4945_CR31","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.3899\/jrheum.100179","volume":"37","author":"JA Husted","year":"2010","unstructured":"Husted JA, Tom BD, Farewell VT, Gladman DD (2010) Longitudinal analysis of fatigue in psoriatic arthritis. J Rheumatol 37:1878\u20131884","journal-title":"J Rheumatol"},{"key":"4945_CR32","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3899\/jrheum.130797","volume":"41","author":"E McDonough","year":"2014","unstructured":"McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD (2014) Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol 41:887\u2013896","journal-title":"J Rheumatol"},{"key":"4945_CR33","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/rheumatology\/keq282","volume":"50","author":"S Hewlett","year":"2011","unstructured":"Hewlett S, Chalder T, Choy E, Cramp F, Davis B, Dures E, Nicholls C, Kirwan J (2011) Fatigue in rheumatoid arthritis: time for a conceptual model. Rheumatology (Oxford) 50:1004\u20131006","journal-title":"Rheumatology (Oxford)"},{"key":"4945_CR34","unstructured":"Guidance for Industry Patient-Reported Outcome Measures. (2009) Use in Medical Product Development to Support Labeling Claims. US Department of Health and Human Services Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER); Center for Devices and Radiological Health (CDRH). www.fda.gov\/downloads\/Drugs\/Guidance ComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf. Accessed 1 Feb 2011"},{"key":"4945_CR35","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/rheumatology\/kep287","volume":"48","author":"P Minnock","year":"2009","unstructured":"Minnock P, Kirwan J, Bresnihan B (2009) Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis. Rheumatology (Oxford) 48:1533\u20131536","journal-title":"Rheumatology (Oxford)"},{"key":"4945_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7224\/1537-2073.2012-011","volume":"15","author":"M Finlayson","year":"2013","unstructured":"Finlayson M, Preissner K, Cho C (2013) Impact of comorbidity on fatigue management intervention outcomes among people with multiple sclerosis: an exploratory investigation. Int J MS Care 15:21\u201326","journal-title":"Int J MS Care"},{"key":"4945_CR37","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/acr.20264","volume":"62","author":"J Nicklin","year":"2010","unstructured":"Nicklin J, Cramp F, Kirwan J, Urban M, Hewlett S (2010) Collaboration with patients in the design of patient-reported outcome measures: capturing the experience of fatigue in rheumatoid arthritis. Arthritis Care Res 62:1552\u20131558","journal-title":"Arthritis Care Res"},{"key":"4945_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2288-14-8","volume":"14","author":"CE Paiva","year":"2014","unstructured":"Paiva CE, Barroso EM, Carneseca EC et al (2014) A critical analysis of test-retest reliability in instrument validation studies of cancer patients under palliative care: a systematic review. BMC Med Res Methodol 14:8","journal-title":"BMC Med Res Methodol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-020-04945-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T00:19:54Z","timestamp":1610842794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-020-04945-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,18]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4945"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-04945-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,18]]},"assertion":[{"value":"14 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Muhammad Haroon received educational grants from AbbVie and Pfizer and has been a member of advisory boards for AbbVie and Celgene.Agnes Szenpetery: None.Mohsin Ashraf: None.Phil Gallagher: None.Oliver FitzGerald has received honoraria and grant support and has been a member of advisory boards for Pfizer, Abbvie, MSD, Roche, UCB, Janssen and Cellgene.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}